Added to YB: 2026-09-15
Pitch date: 2026-09-11
BAYN.DE [bullish]
Bayer Aktiengesellschaft
+1.67%
current return
Author Info
No bio for this author
Company Info
Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil.
Market Cap
EUR 47.3B
Pitch Price
EUR 48.52
Price Target
N/A
Dividend
0.23%
EV/EBITDA
7.75
P/E
-27.23
EV/Sales
1.78
Sector
Pharmaceuticals
Category
value
Theodosian Capital | Stocks Update 11/9/2026 - Bayer Aktiengesellschaft
BAYN.DE (watchlist): Bayer shows signs of nearing the end of its litigation-heavy chapter: Monsanto secured a landmark U.S. Supreme Court Roundup case in June, followed by Bayer placing its glyphosate units into standalone Ruveon in July, potentially signaling optionality around the business’s future strategy and ownership. Crop Science targets free-cash-flow growth from €1.4bn in 2025 to over €3bn by 2029; shares trade at 10.2x 2027 consensus earnings despite €29-30bn of guided end-2026 net debt.
Read full article (2 min)